PharmaEssentia Corporation, Taichung Plant

FDA 483 - PharmaEssentia Corporation, Taichung Plant

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PharmaEssentia Corporation, Taichung Plant

Record Details

An FDA inspection of PharmaEssentia Corporation, Taichung Plant, a drug substance manufacturer, revealed two significant observations. The firm failed to adequately investigate complaints of lack of therapeutic efficacy, neglecting to review manufacturing records, analytical data, or retention samples. Additionally, the bacterial endotoxin testing method was found to be inadequate due to issues with sample container validation and the use of uncalibrated equipment.

Company: PharmaEssentia Corporation, Taichung Plant
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Jeffrey P. Raimondi (Consumer Safety Officer)

Open in Dashboard

ID · 9dc88250-9156-45aa-a21a-70c437863018